Examining vitamin B12 levels in stroke patients
SERUM VITAMIN B12 LEVELS IN PATIENTS WITH HEMORRHAGIC VS ISCHEMIC CEREBROVASCULAR EVENT.
This study looks at vitamin B12 levels in stroke patients to see if there's a difference between those with bleeding strokes and those with blocked blood flow, and how this might relate to their health outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hospital General de Mexicali Academic / other |
| Locations | 1 site (Mexicali, Baja California) |
| Trial ID | NCT06190314 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare serum vitamin B12 levels in patients diagnosed with hemorrhagic versus ischemic cerebrovascular events. It will involve a prospective analysis of hospitalized patients at the General Hospital of Mexicali, focusing on demographic characteristics, comorbidities, and laboratory diagnoses. The study will also assess the prevalence of vitamin B12 deficiency and its correlation with disease severity and mortality. Data will be collected from electronic clinical records and will include all eligible patients presenting with stroke symptoms.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old who have been hospitalized with a diagnosis of either ischemic or hemorrhagic stroke.
Not a fit: Patients who do not undergo laboratory testing during hospitalization or lack a cranial CT scan will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into the role of vitamin B12 in stroke outcomes, potentially guiding treatment and prevention strategies.
How similar studies have performed: While the relationship between vitamin B12 levels and stroke outcomes has been explored in other studies, this specific comparison between hemorrhagic and ischemic strokes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18 years * Have a diagnosis of a cerebral vascular event * Being a hospitalized patient at the General Hospital of Mexicali Exclusion Criteria: * Patients without lab tests during their hospitalization * Patients without a cranial CT scan
Where this trial is running
Mexicali, Baja California
- General Hospital of Mexicali — Mexicali, Baja California, Mexico (Recruiting)
Study contacts
- Study coordinator: Hiram Jaramillo, MD
- Email: grupoinvestigacionmedica@gmail.com
- Phone: 6861358412
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.